U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C19H17NO7
Molecular Weight 371.3408
Optical Activity UNSPECIFIED
Defined Stereocenters 3 / 3
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of INCYCLINIDE

SMILES

NC(=O)C1=C(O)C[C@@H]2C[C@@H]3CC4=C(C(O)=CC=C4)C(=O)C3=C(O)[C@]2(O)C1=O

InChI

InChIKey=ZXFCRFYULUUSDW-OWXODZSWSA-N
InChI=1S/C19H17NO7/c20-18(26)14-11(22)6-9-5-8-4-7-2-1-3-10(21)12(7)15(23)13(8)16(24)19(9,27)17(14)25/h1-3,8-9,21-22,24,27H,4-6H2,(H2,20,26)/t8-,9-,19-/m0/s1

HIDE SMILES / InChI

Molecular Formula C19H17NO7
Molecular Weight 371.3408
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 3 / 3
E/Z Centers 0
Optical Activity UNSPECIFIED

Iincyclinide, also known as CMT-3 and COL-3, is an MMP inhibitor and a chemically-modified tetracycline with potential antineoplastic activity patented by Chas. Pfizer & Co. Incyclinide has been shown to experimentally suppress prostate cancer, colon adenocarcinoma and melanoma invasiveness in cell culture. Incyclinide is an especially effective inhibitor of the growth and viability of filamentous fungi. Unfortunately, in clinical trials, Iincyclinide failed to demonstrate efficacy in Lymphoma, Melanoma, Renal Cell Carcinoma, and some other tumors.

Approval Year

Targets

Targets

PubMed

PubMed

TitleDatePubMed
Chemically modified tetracyclines induce apoptosis in cultured mast cells.
2005-10
Chemically modified tetracycline (CMT)-3 inhibits histamine release and cytokine production in mast cells: possible involvement of protein kinase C.
2005-07
Effect of chemically modified tetracycline on transforming growth factor-beta1 and caspase-3 activation in liver of septic rats.
2005-07
Cyclooxygenase-2 inhibitor celecoxib augments chemotherapeutic drug-induced apoptosis by enhancing activation of caspase-3 and -9 in prostate cancer cells.
2005-06-20
Role of chemically modified tetracycline on TNF-alpha and mitogen-activated protein kinases in sepsis.
2004-11
A nonantibiotic chemically modified tetracycline (CMT-3) inhibits intimal thickening.
2003-10
Inhibition of cell proliferation, invasion, tumor growth and metastasis by an oral non-antimicrobial tetracycline analog (COL-3) in a metastatic prostate cancer model.
2002-03-10
Reversible sideroblastic anemia associated with the tetracycline analogue COL-3.
2001-05
Cytotoxic activity and inhibition of tumor cell invasion by derivatives of a chemically modified tetracycline CMT-3 (COL-3).
2001-02
CMT-3, a non-antimicrobial tetracycline (TC), inhibits MT1-MMP activity: relevance to cancer.
2001-02
Patents

Patents

Sample Use Guides

50 mg/day and 100 mg/day
Route of Administration: Oral
Substance Class Chemical
Created
by admin
on Mon Mar 31 21:22:52 GMT 2025
Edited
by admin
on Mon Mar 31 21:22:52 GMT 2025
Record UNII
21G64WZQ4I
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
INCYCLINIDE
INN   USAN  
INN   USAN  
Official Name English
(4aS,5aR,12aS)-3,10,12,12a-Tetrahydroxy-1,11-dioxo-1,4,4a,5,5a,6,11,12a-octahydrotetracene-2-carboxamide
Preferred Name English
NSC-683551
Code English
METASTAT
Brand Name English
2-NAPHTHACENECARBOXAMIDE, 1,4,4A,5,5A,6,11,12A-OCTAHYDRO-3,10,12,12A-TETRAHYDROXY-1,11-DIOXO-, (4AS,5AR,12AS)-
Common Name English
INCYCLINIDE [USAN]
Common Name English
incyclinide [INN]
Common Name English
COL-3
Code English
Classification Tree Code System Code
NCI_THESAURUS C1970
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
Code System Code Type Description
NSC
683551
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
WIKIPEDIA
Incyclinide
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
USAN
RR-11
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
NCI_THESAURUS
C2454
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
PUBCHEM
54678924
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
ChEMBL
CHEMBL2104970
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
CAS
15866-90-7
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
SMS_ID
300000034248
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
EPA CompTox
DTXSID801032905
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
FDA UNII
21G64WZQ4I
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
INN
8698
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
DRUG BANK
DB11647
Created by admin on Mon Mar 31 21:22:52 GMT 2025 , Edited by admin on Mon Mar 31 21:22:52 GMT 2025
PRIMARY
Related Record Type Details
ACTIVE MOIETY